Jeff Lagasse
With a rate announcement expected soon, MedPAC cautions that MA may worsen Medicare's sustainability.
The popularity of MA has exploded, but AHIP officials want to protect MA before the end of the pandemic signals a shift in flexibilities.
The program touts evidence of higher-quality outcomes at lower costs for patients compared to traditional acute care.
The funding is for organizations working to address the upstream social determinants of health impacting the likelihood of developing diabetes.
This spending growth resulted from strong federal support in 2020 and waning support in 2021, the numbers showed.
The move was made to avoid potential staffing issues and to give healthcare workers more time to comply.
The expectation is that customers will be able to minimize the risk of missing rebate program revenue targets and receive rebate funds more quickly.
Costs per single treatment for drugs administered in hospitals were an average of $7,000 more than those purchased through specialty pharmacies.
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.
Sara Serritella of the University of Chicago will spin her tale during the HIMSS22 annual conference in Orlando next month.